XHIST Multiscale 3D virtual histology with non-destructive x-rays
- Coordinator
- Danmarks Tekniske Universitet, Denmark
- Runs
- 1 October 2026 to 31 March 2028
- Status
- Running
- EU funding
- €150k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101335496
What the project is doing
In the project's own words, from its summary on CORDIS.
XHIST aims to introduce three-dimensional virtual histology into clinical pathology using non-destructive X-ray phase-contrast tomography. Conventional histopathology relies on micrometre-thin slices cut from standardized formalin-fixed paraffin-embedded (FFPE) tissue blocks. By slicing, routinely only about 1% of the tissue in these millimeter-thick blocks is assessed and the three-dimensional organisation can only be extrapolated.
XHIST mitigates these constraints by enabling volumetric imaging of entire FFPE tissue blocks with sub-micron voxel size, spatial resolution comparable to conventional histopathology, but without staining or destructive preparation and all within a time frame of two hours. The technology builds on advances from ERC-funded research in multiscale X-ray imaging. A newly developed 150-megapixel detector, combined with high-brightness X-ray sources and phase-contrast reconstruction methods, enables simultaneous large field-of-view imaging and high spatial resolution, allowing cellular structures to be visualised across entire tissue volumes.
The objective of this Proof-of-Concept project is to translate this technology toward clinical use by developing a prototype scanner, automated acquisition and reconstruction workflows, and visualisation tools that integrate with existing pathology practice. The system will be validated in the clinical cases; (i) tumour margin assessment and (ii) detection of microvascular invasion in liver cancer. The project will also develop an intellectual property and commercialization strategy aimed at translating XHIST into a deployable stand-alone imaging platform for hospital pathology laboratories, the primary market for the technology, and laying the foundation for a future start-up commercializing the system.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Danmarks Tekniske Universitet | Kongens Lyngby | Denmark | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI